These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 21355813)

  • 1. Relationship between insight into cognition, extrapyramidal symptoms and mental illness in schizophrenia.
    Zhornitsky S; Potvin S; Aubin G; Stip E
    Aust N Z J Psychiatry; 2011 Jul; 45(7):604-5. PubMed ID: 21355813
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of antipsychotic replacement with quetiapine on the symptoms and quality of life of schizophrenic patients with extrapyramidal symptoms.
    Taniguchi T; Sumitani S; Aono M; Iga J; Kinouchi S; Aki H; Matsushita M; Taniguchi K; Tsuno M; Yamanishi K; Tomotake M; Kaneda Y; Ohmori T
    Hum Psychopharmacol; 2006 Oct; 21(7):439-45. PubMed ID: 17029303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of short term outcome in schizophrenia: depressive symptoms, negative symptoms, and extrapyramidal signs. Treatment Strategies in Schizophrenia Collaborative Study Group.
    Glick ID; Jacobs M; Lieberman J; Simpson G; Schooler NR
    Psychopharmacol Bull; 1989; 25(3):344-7. PubMed ID: 2626513
    [No Abstract]   [Full Text] [Related]  

  • 4. The relationship between depressive symptoms and subjective well-being in newly admitted patients with schizophrenia.
    Kim JH; Ann JH; Kim MJ
    Compr Psychiatry; 2010; 51(2):165-70. PubMed ID: 20152297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible predictors of neuroleptic-resistant schizophrenic relapse: influence of negative symptoms and acute extrapyramidal side effects.
    Kinon BJ; Kane JM; Chakos M; Munne R
    Psychopharmacol Bull; 1993; 29(3):365-9. PubMed ID: 7907184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap between emotional blunting, depression, and extrapyramidal symptoms in schizophrenia.
    Müller M
    Schizophr Res; 2002 Oct; 57(2-3):307. PubMed ID: 12223263
    [No Abstract]   [Full Text] [Related]  

  • 7. Extrapyramidal symptoms in unmedicated schizophrenia.
    McCreadie RG; Srinivasan TN; Padmavati R; Thara R
    J Psychiatr Res; 2005 May; 39(3):261-6. PubMed ID: 15725424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of basal ganglionic dysfunction for schizophrenia.
    Lidsky TI; Weinhold PM; Levine FM
    Biol Psychiatry; 1979 Feb; 14(1):3-12. PubMed ID: 420906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and differential diagnosis of depressive syndromes in schizophrenia.
    Martin RL; Cloninger CR; Guze SB; Clayton PJ
    J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses.
    Jahn T; Hubmann W; Karr M; Mohr F; Schlenker R; Heidenreich T; Cohen R; Schröder J
    Psychiatry Res; 2006 Jun; 142(2-3):191-9. PubMed ID: 16650902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linguistic ability and mental health outcomes among deaf people with schizophrenia.
    Horton HK
    J Nerv Ment Dis; 2010 Sep; 198(9):634-42. PubMed ID: 20823724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extrapyramidal symptoms in substance abusers with and without schizophrenia and in nonabusing patients with schizophrenia.
    Zhornitsky S; Stip E; Pampoulova T; Rizkallah E; Lipp O; Bentaleb LA; Chiasson JP; Potvin S
    Mov Disord; 2010 Oct; 25(13):2188-94. PubMed ID: 20669315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing negative symptoms and extrapyramidal symptoms in schizophrenia: workshop report.
    Kane JM; Dauphinais D; Barnes TR; Adler LA; Rifkin A
    Psychopharmacol Bull; 1993; 29(1):45-9. PubMed ID: 8104351
    [No Abstract]   [Full Text] [Related]  

  • 14. [Motor disturbances in psychiatric patients].
    Rüther E
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S3-6. PubMed ID: 15818515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study.
    Bobes J; Arango C; Garcia-Garcia M; Rejas J;
    J Clin Psychiatry; 2010 Mar; 71(3):280-6. PubMed ID: 19895779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
    Honer WG; Kopala LC; Rabinowitz J
    J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive effects of ziprasidone and related factors in patients with chronic schizophrenia undergoing usual care: a 12-month, open-label, flexible-dose, naturalistic observational trial.
    Gibel A; Ritsner MS
    Clin Neuropharmacol; 2008; 31(4):204-20. PubMed ID: 18670244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptoms of schizophrenia and social cognition.
    Shean G; Meyer J
    Psychiatry Res; 2009 Dec; 170(2-3):157-60. PubMed ID: 19906436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alignment and theory of mind in schizophrenia.
    Stewart SL; Corcoran R; Drake RJ
    Cogn Neuropsychiatry; 2008 Sep; 13(5):431-48. PubMed ID: 18781495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.